Primary refractory acute myeloid leukaemia ― in search of better definitions and therapiesRAVANDI, Farhad.British journal of haematology. 2011, Vol 155, Num 4, pp 413-419, issn 0007-1048, 7 p.Article

Immune defects in patients with chronic lymphocytic leukemia : Immunotherapy in Chronic Lymphocytic LeukemiaRAVANDI, Farhad; O'BRIEN, Susan.Cancer immunology and immunotherapy. 2006, Vol 55, Num 2, pp 197-209, issn 0340-7004, 13 p.Article

Infections associated with purine analogs and monoclonal antibodiesRAVANDI, Farhad; O'BRIEN, Susan.Blood reviews. 2005, Vol 19, Num 5, pp 253-273, issn 0268-960X, 21 p.Article

Eradication of leukemia stem cells as a new goal of therapy in leukemiaRAVANDI, Farhad; ESTROV, Zeev.Clinical cancer research. 2006, Vol 12, Num 2, pp 340-344, issn 1078-0432, 5 p.Article

AlemtuzumabRAVANDI, Farhad; O'BRIEN, Susan.Expert review of anticancer therapy. 2005, Vol 5, Num 1, pp 39-51, issn 1473-7140, 13 p.Article

Chronic lymphoid leukemias other than chronic lymphocytic leukemia : Diagnosis and treatmentRAVANDI, Farhad; O'BRIEN, Susan.Mayo Clinic proceedings. 2005, Vol 80, Num 12, pp 1660-1674, issn 0025-6196, 15 p.Article

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia: The Start of an Era?PEMMARAJU, Naveen; KANTARJIAN, Hagop; RAVANDI, Farhad et al.Cancer. 2011, Vol 117, Num 15, pp 3293-3304, issn 0008-543X, 12 p.Article

Cellular signalling pathways: New targets in leukaemia therapyRAVANDI, Farhad; TALPAZ, Moshe; KANTARJIAN, Hagop et al.British journal of haematology. 2002, Vol 116, Num 1, pp 57-77, issn 0007-1048Article

Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaRAVANDI, Farhad; KEBRIAEI, Partow.Hematology/oncology clinics of North America. 2009, Vol 23, Num 5, issn 0889-8588, vi, 1043-1063 [22 p.]Article

Modulation of cellular signaling pathways: Prospects for targeted therapy in hematological malignanciesRAVANDI, Farhad; TALPAZ, Moshe; ESTROV, Zeev et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 535-550, issn 1078-0432, 16 p.Article

New agents in acute myeloid leukemia and other myeloid disordersRAVANDI, Farhad; KANTARJIAN, Hagop; GILES, Francis et al.Cancer. 2004, Vol 100, Num 3, pp 441-454, issn 0008-543X, 14 p.Article

Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implicationsRAVANDI, Farhad; VERMA, Amit; RIDGEWAY, Jean et al.Leukemia research. 2003, Vol 27, Num 9, pp 853-857, issn 0145-2126, 5 p.Article

Purine analogue combinations for indolent lymphomasDI BELLA, Nicholas; RAVANDI, Farhad.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S11-S21, SUP2Conference Paper

Targeted Therapies in Hematology and Their Impact on Patient Care: Chronic and Acute Myeloid LeukemiaJABBOUR, Elias; CORTES, Jorge; RAVANDI, Farhad et al.Seminars in hematology. 2013, Vol 50, Num 4, pp 271-283, issn 0037-1963, 13 p.Article

Acute Promyelocytic Leukemia: A Population-Based Study on Incidence and Survival in the United States, 1975-2008YIMING CHEN; KANTARJIAN, Hagop; HAIJUN WANG et al.Cancer. 2012, Vol 118, Num 23, pp 5811-5818, issn 0008-543X, 8 p.Article

Monoclonal antibody therapy for hairy cell leukemiaTHOMAS, Deborah A; RAVANDI, Farhad; KANTARJIAN, Hagop et al.Hematology/oncology clinics of North America. 2006, Vol 20, Num 5, issn 0889-8588, vii, 1125-1136 [13 p.]Article

Purine analogues in advanced T-cell lymphoid malignanciesKURZROCK, Razelle; RAVANDI, Farhad.Seminars in hematology. 2006, Vol 43, Num 2, issn 0037-1963, S27-S34, SUP2Conference Paper

Results of the Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Regimen in Elderly Patients With Acute Lymphocytic LeukemiaO'BRIEN, Susan; THOMAS, Deborah A; RAVANDI, Farhad et al.Cancer. 2008, Vol 113, Num 8, pp 2097-2101, issn 0008-543X, 5 p.Article

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myelomaHUSSEIN, Mohamad A; SALEH, Mansoor; RAVANDI, Farhad et al.British journal of haematology. 2004, Vol 125, Num 4, pp 470-476, issn 0007-1048, 7 p.Article

The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid LeukemiaLEE, Hun Ju; DAVER, Naval; KANTARJIAN, Hagop M et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 327-335, issn 1078-0432, 9 p.Article

Potential Cure of Acute Myeloid Leukemia : Analysis of 1069 Consecutive Patients in First Complete RemissionYANADA, Masamitsu; GARCIA-MANERO, Guillermo; BORTHAKUR, Gautam et al.Cancer. 2007, Vol 110, Num 12, pp 2756-2760, issn 0008-543X, 5 p.Article

Acute Promyelocytic Leukemia at Time of Relapse Commonly Demonstrates Cytogenetic Evidence of Clonal Evolution and Variability in Blast Immunophenotypic FeaturesDIMOV, Nikolay D; MEDEIROS, L. Jeffrey; RAVANDI, Farhad et al.American journal of clinical pathology. 2010, Vol 133, Num 3, pp 484-490, issn 0002-9173, 7 p.Article

The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approachSIVINA, Mariela; KREITMAN, Robert J; ARONS, Evgeny et al.British journal of haematology. 2014, Vol 166, Num 2, pp 177-188, issn 0007-1048, 12 p.Article

Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cellsBALAKRISHNAN, Kumudha; NIMMANAPALLI, Ramadevi; RAVANDI, Farhad et al.Blood. 2006, Vol 108, Num 7, pp 2392-2398, issn 0006-4971, 7 p.Article

Mature T-cell leukemiasRAVANDI, Farhad; KANTARJIAN, Hagop; JONES, Dan et al.Cancer. 2005, Vol 104, Num 9, pp 1808-1818, issn 0008-543X, 11 p.Article